Monday, January 5, 2009

ACCC, ASCO, & CMS News

The following information has been received by ANCO.


****ACCC NEWS****
The Association of Community Cancer Center's (ACCC) This Week At ACCC was published today and is available online at http://www.accc-cancer.org/mediaroom/newsletters/2009/media_ACCCNEWSLETTER_1-05-2009.html. ANCO is an Institutional Member of ACCC. This edition features:

ACCC Submits Comments to CMS on HOPPS Final Rule

Register Today: March 18-21, 2009, ACCC's 35th Annual National Meeting

FDA Approves New Drug for Prostate Cancer

New Spanish Language Educations Resources Available from NCI

ACCC’s Drug Database and Compendia-Based Drug Bulletin Put on Hold

Q&A on ACCC's Listserv: ESA Claims and Coding

ACCC's CE Blackboard: Lung Cancer, Year in Review

Take Our Survey: Oncology Issues and ACCC's Website

State Medical Oncology Societies Host Membership Meetings


****ASCO NEWS****
The American Society of Clinical Oncology's (ASCO) e-News was published today and is available at http://view.exacttarget.com/?j=fe571578736d02757714&m=ff2d16787160&ls=fdf112797d60067f7116717d&l=fe52157576620c787c1c&s=fdf2157972640d79751d7073&jb=ffcf14&ju=fe3316717d640678721572. ANCO is a state/regional affiliate of ASCO. This edition features:

2009 ASCO Election Results Now Available Online

ASCO Recognized by FDA and Honored with Award

Deadline Approaching to Submit an Abstract for the 2009 ASCO Annual Meeting

ASCO's Newest Issue of Clinical Cancer Advances Now Available Online

Cancer Policy Alert: Year End Update on Cancer Policy Activities

Early Registration Deadline for the 2009 GU Cancers Symposium: Jan. 23

Read the Newest JCO Original Report on the Phase II Trial of Sorafenib in Patients with Metastatic Breast Cancer

Read the Newest JOP Feature, "Continued Regulatory Actions Affecting the Use of Erythropoiesis-Stimulating Agents (ESAs)"

Apply for the Medical Student Rotation, funded by Susan G. Komen for the Cure®

Apply for the Resident Travel Award, funded by Susan G. Komen for the Cure®

Don't Miss Out on the Event, Cancer Advances: A Public Forum on Gastrointestinal Cancers

Cancer.Net Feature: Top Cancer Advances in 2008

Cancer.Net Podcast: Clinical Cancer Advances 2008


****CMS NEWS****
MM6328 – Claim Status Category Code and Claim Status Code Update
http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM6328.pdf

MM6290 – Quarterly Update to Correct Coding Initiative (CCI) Edits, Version 15.0, Effective January 1, 2009
http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM6290.pdf

Tuesday, December 30, 2008

ASCO News

The following information has been received by ANCO.


****ASCO NEWS****
The Food & Drug Administration (FDA) and the American Society for Health-System Pharmacists (ASHP) have recently reported a shortage of cisplatin 1 mg/mL injections. The shortage has been reported by the three manufacturers; Bedford, Teva, and APP. APP currently has some availability, and Teva is on backorder with an expected release date sometime in January 2009. At this time Bedford is backordered and no release date is being provided.

The shortage of Leucovorin remains and no additional information on the manufacturing delays or release dates have been provided by Bedford or Teva.

More detailed information on these shortages can be found at the FDA website at http://www.fda.gov/cder/drug/shortages/default.htm#Current and the ASHP website at http://www.ashp.org/DrugShortages/Current/.

Monday, December 29, 2008

ACCC & ANCO News

The following information has been received by ANCO.


****ACCC NEWS****
The Association of Community Cancer Center's (ACCC) This Week At ACCC was published today and is available online at http://www.accc-cancer.org/mediaroom/newsletters/media_ACCCNEWSLETTER_12-29-2008.html. ANCO is an Institutional Member of ACCC. This edition features:

UnitedHealthcare Changes Requirement Related to Herceptin Coverage

Register Today: March 18-21, 2009, ACCC's 35th Annual National Meeting

FDA Approves Gleevec for New Indication

Welcome Aboard to ACCC's Newest Cancer Program Members

ACCC’s Drug Database and Compendia-Based Drug Bulletin Put on Hold

ACCC's Website to Be Upgraded and Improved

Oncology Review Journal Available Online to ACCC Members

Q&A on ACCC's Listserv: Smoking Cessation, K-ras Testing

ACCC's CE Blackboard: Lung Cancer, Year in Review

Take Our Survey: Oncology Issues and ACCC's Website

State Medical Oncology Societies Host Membership Meetings


****ANCO NEWS****
The Association of Northern California Oncologists (ANCO), Leukemia & Lymphoma Society, & Indiana University present

ASH Highlights 2008
Tuesday, February 10th, 2009; 5:30PM-9:15PM
Hotel Nikko, 222 Mason Street, San Francisco
(415) 394-1111

The Association of Northern California Oncologists was organized in 1990 to be an advocate for, educate, and inform the practicing oncologist and hematologist and represents 363 oncologists and hematologists throughout Northern California and other states.

ASH Highlights 2008 will summarize the major research and treatment advancements presented at December 2008’s ASH Annual Meeting. The program will focus on surgical, radiation, and medical oncology treatment modalities for hematological malignancies. The faculty will place these developments in context as to their immediate clinical utility.

Educational Objectives. At the conclusion of this educational activity, participants were able to:

• Review, summarize, and interpret important clinical results presented at the 2008 ASH Annual Meeting for surgical, radiation, and medical oncologists; oncology nurses; and, other health care professionals.

• Comprehend and implement of changes in treatment for hematological malignancies.

Target Audience. ASH Highlights 2008 has been designed to meet the educational needs of oncologists, oncology nurses, oncology pharmacists, and other health care professionals involved in the care of people with hematological malignancies.

Accreditation Statement and Designation of Credit. This activity was planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Indiana University School of Medicine and the Association of Northern California Oncologists (ANCO). The Indiana University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Indiana University School of Medicine designated this educational activity for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The California Board of Registered Nurses accepts courses approved for AMA PRA Category 1 Credits as meeting the continuing education requirements for renewal.

Disclosure Statement. In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by the Indiana University School of Medicine (IUSM) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and Planning Committee members participating in an IUSM-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Program Planning Committee. The Physician Course Director for ASH Highlights 2008 is Steven Coutre, M.D., Stanford Univ. Dr. Coutre was assisted by the ANCO Board of Directors (Richard A. Bohannon, M.D., Norman Cohen, M.D., Jeffrey Cronk, M.D., Bradley Ekstrand, M.D., Ellie Guardino, M.D., Ph.D., John A. Keech, Jr., D.O., L. Wayne Keiser, M.D., Primo Lara, Jr., M.D., Daniel P. Mirda, M.D., Bimal J. Patel, M.D., Robert L. Robles, M.D., and Antoine Sayegh, M.D.) and Group and Institutional Member contacts (George Fisher, M.D., David Gandara, M.D., Joseph Mason, M.D., Hope Rugo, M.D., and Margaret Tempero, M.D.) in the selection of the faculty for ASH Highlights 2008..

Content Consultant. The Indiana University School of Medicine content consultant was Larry D. Cripe, M.D., Associate Professor of Hematology/Oncology.

Agenda & Faculty
5:30PM Registration, Exhibits, & Dinner (available through 7:00PM)

6:00PM Welcome, Introductions, & Talks
Richard A. Bohannon, M.D., ANCO President
Steven E. Coutre, M.D., Program Moderator, Stanford Univ.

Leukemia
Bruno Carneiro de Medeiros, M.D., Stanford Univ.

Lymphoma
Joseph Tuscano, M.D., Univ. of California, Davis

Multiple Myeloma
Steven E. Coutre, M.D., Stanford Univ.

Myelodysplastic Syndrome
Jason R. Gotlib, M.D., Stanford Univ.

9:15PM Adjourn

Acknowledgment of Commercial Support. Support for this educational activity is anticipated in part from Alaven, biogenIDEC, Celgene, Cephalon Oncology, Eisai, Enzon Pharmaceuticals, Genentech BioOncology, Genzyme Oncology, GlaxoSmithKline Oncology, Millennium, Ortho Biotech, and possibly others (as of the date of this mailing). The final list of supporters will be available at the meeting.

Download the meeting announcement/registration form at www.anco-online.org/ash.html.

Sunday, December 28, 2008

ASH, NCCN, & UHC News

The following information has been received by ANCO.


****ASH NEWS****
The American Society of Hematology's (ASH) Practice Update was published recently and is available online at http://www.hematology.org/policy/practice. This edition features:

President-Elect Obama Nominates Daschle for HHS Secretary

Medicare Releases E-Prescribing Measure

New Report Analyzes 2007 PQRI Program Reporting Experience

ASH Submits Comments in Support of Iron Serum Study NCD

ASH Launches New Practice Page

Value-Based Purchasing Plan for Physicians Under Development at CMS


****NCCN NEWS****
NOW ON LINE! Northern California Cancer Center’s 2nd Annual Cancer Survivorship Conference held on November 8, 2008

To listen to and view go to www.nccc.org. and click on “Program Presentations” or http://www.nccc.org/site/c.foJNIXOyEpH/b.2913703/

Another Multiple Choice Test
Joan Venticinque, Cancer Survivor

Psychosocial Issues
Jeremy E. Bornstein, PhD, CPMC

A Life on Hold
Gregg Timmons, Cancer Survivor

Medical Issues
Sandra Horning, MD/Stanford

Transitioning from Oncologist to Primary Care Doctor
Judy Luce, MD/UCSF

Please mark your calendars! The 3rd Annual Post-Treatment Cancer Survivorship Conference is scheduled for November 14, 2009.


****UHC NEWS****
UnitedHealthcare is removing the requirement to submit a pathology report to obtain coverage for trastuzumab. This change will be effective for claims submitted after 1/1/2009.

Herceptin claims that were submitted in 2008 that are pending payment will require the submission of the pathology report showing over expression of the HER2 gene. The pathology reports should be faxed to 915-231-1970 and you should use the dedicated fax cover sheet.

Herceptin claims submitted after 1/1/2009 will continue to be subjected to two reimbursement policies that may impact the reimbursement. The National Comprehensive Cancer Network (NCCN) policy and the Maximum Dosage Edit policy both review Herceptin claims. Both of these policies are posted on the unitedhealthcareonline web site.

UnitedHealthcare launched the Herceptin policy in early 2006 based on an audit showing that 12 percent of the patients being treated with trastuzumab did not have over-expression of the HER2 gene. Our last audit in September 2008, demonstrated that less than 1 percent of the submissions failed to show over- expression.

Our medical policy hasn’t changed – treatment of patients with under-expression is still inappropriate. We believe the recent audit demonstrates that this quality parameter is being followed and no longer requires the quality check.

There are other critical issues with HER2 gene expression testing. Studies show that concordance between local laboratories and a central laboratory with quality controls can be poor. The College of American Pathology has established accreditation for HER2 gene testing, but participation in the accreditation process is voluntary. UnitedHealthcare contracts with two national laboratories, Genezyme and Lab Corporation that meet the ASCO / CAP guideline recommendations and proficiency testing for HER2. We encourage the use of laboratories that meet these standards. If you don’t know the accreditation status of your current lab for HER2, we would encourage retesting, or a second opinion, from either of these laboratories for your UnitedHealthcare patients.

Tuesday, December 23, 2008

CMS News

The following information has been received by ANCO.


****CMS NEWS****
Beginning December 19, 2008, the names of physicians and other health care professionals who reported quality information under the Physician Quality Reporting Initiative (PQRI) in 2007 will be available at www.medicare.gov\physician, the Physician and Other Healthcare Professional Directory located on www.medicare.gov. This information includes all eligible professionals identified by their National Provider Identifier (NPI) who submitted at least one quality data code on their Medicare claims for services furnished between July 1, 2007 and December 31, 2007.

The PQRI is a voluntary reporting program. A physician or other healthcare professional can choose whether to report quality information to Medicare under the PQRI program. Reporting quality information by professionals is an important means to promote improved quality of care to Medicare beneficiaries. There are, however, numerous reasons why physicians or other healthcare professionals, who are committed to providing high quality care to their patients, may have chosen not to report quality information under the PQRI Program which began in 2007.

For more information on the PQRI and the instructions for reporting and requirements for satisfactory reporting, go to http://www.cms.hhs.gov/pqri.
Detailed information on the 2009 PQRI may be found in the 2009 Medicare Physician Fee Schedule final rule with comment period (73 FR 69817 through 69847) that was published in the Federal Register on November 19, 2008. The final rule with comment period can be found in the “Related Links Outside of CMS” section of the Physician Quality Reporting Initiative website at: http://edocket.access.gpo.gov/2008/pdf/E8-26213.pdf on the CMS website.

Reporting for the 2009 PQRI begins January 1, 2009. Please note there is no need to sign up or pre-register in order to participate.

ACCC, ASCO, & CMA News

The following information has been received by ANCO.


****ACCC NEWS****
The Association of Community Cancer Center's (ACCC) This Week At ACCC was published today and is available online at http://www.accc-cancer.org/mediaroom/newsletters/media_ACCCNEWSLETTER_12-22-2008.html. ANCO is an Institutional Member of ACCC. This edition features:

IOM Document on Colorectal Cancer Screening Available Online

Register Today: March 18-21, 2009, ACCC's 35th Annual National Meeting

FDA Approves Genzyme's Mozobil

ACCC’s Drug Database and Compendia-Based Drug Bulletin Put on Hold

ACCC's Website to Be Upgraded and Improved

Prostate Cancer Prevention Study Shows No Benefit for Use of Selenium and Vitamin E Supplements

Oncology Review Journal Available Online to ACCC Members

Q&A on ACCC's Listserv: Incentivizing Hospital-Employed Medical Oncologists

ACCC's CE Blackboard: Lung Cancer, Year in Review

Take Our Survey: Oncology Issues and ACCC's Website

State Medical Oncology Societies Host Membership Meetings


****ASCO NEWS****
The American Society of Clinical Oncology's (ASCO) e-News was published today and is available online at http://view.exacttarget.com/?j=fe54157873650d757c15&m=ff2d16787160&ls=fdf112797d60067f7116717d&l=fe52157576620c787c1c&s=fdf2157972640d79751d7073&jb=ffcf14&ju=fe3216717260057b741774. ANCO is a state/regional affiliate of ASCO. This edition features:

ASCO Recognized by FDA and Honored with Award

Cancer Policy Alert: FDA Issues Q&A on Medication Guides for ESAs; ASCO Launches Health Information Technology Social Networking Site

Check Out the Newest JCO Original Report on In Vivo Electroporation

Read the Newest JOP Feature, "Continued Regulatory Actions Affecting the Use of Erythropoiesis-Stimulating Agents (ESAs)"

Still Time to Register for the Jan. 15-17 GI Cancers Symposium

Early Registration Deadline for the 2009 GU Cancers Symposium: Jan. 23

Application Deadline for the 2009 IDEA Award: Jan. 14

Application Deadline for the 2009 ASCO Loan Repayment Program, Funded by Susan G. Komen for the Cure®: Jan. 15

Apply for the Medical Student Rotation, funded by Susan G. Komen for the Cure®

Apply for the Resident Travel Award, funded by Susan G. Komen for the Cure®

Check Out the Event, Cancer Advances: A Public Forum on Gastrointestinal Cancers

ASCO Expert Corner: Cancer Rates Across the Globe

Cancer.Net Feature: Seven Steps for a Healthier New Year

Cancer.Net Podcast: Cancer and the Winter Months


****CMA News****
The California Medical Association's (CMA) Alert was published today and is available online at http://www.calphys.org/html/news.asp. It featues:

Medical Board Changes CME Reporting Requirements

Obama Administration Looks at Health Care Reform

Physicians Can Earn 2% Medicare Bonus for e-Prescribing

Deadline to Make Medicare Participation Decisions for
2009 Is 12/31

Order CMA's 2009 Model Medical Staff Bylaws

CMA Foundation Publishes 2009 Antibiotic Awareness Toolkit

Save the Date: 2009 Leadership Academy

Benefit of the Week: 30-50% off Epocrates

Saturday, December 20, 2008

ASCO, CMS, DHCS/MediCal, & Palmetto/J1MAC News

The following information has been received by ANCO.

All ANCO Online LIstServ postings are archived at the ANCO Online ListSev blog available at http://anco-online.blogspot.com/.


****ASCO NEWS****
The American Society of Clinical Oncology's (ASCO) Cancer Policy Today was published and is available online at http://view.exacttarget.com/?j=fe591578736405747c10&m=ff311d707460&ls=fdec12777c65017975127971&l=fe601575776601757d14&s=fe1f15797d620479731d75&jb=ffcf14&ju=fe2f167172660174711472. ANCO is a state/regional affiliate of ASCO. This edition features:

NIH Funding Appropriations Update

Update on Medicare Payment Provisions

Status of Legislation to Coordinate Treatment Care Planning

Update on E-Prescribing Initiatives

Genetic Nondiscrimination Bill Signed Into Law

ASCO Oncology Workforce Initiatives Update

Review of ESA Label Revisions

FDA Recognizes ASCO for Partnership on Critical Path Initiative

Update on Insurance Coverage of Clinical Trials

QOPI Update

Update on Expanded Access to Unapproved Drugs

Four Physicians Join the 111th Congress

President-elect Obama's Transition Team Reaches Out to Public on Health Care

ASCO Issues New Clinical Practice Guidelines

ASCO Creates Generic Chemotherapy Treatment Plan and Summary

ASCO Designs Modifiable Chemotherapy Consent Form

ASCO Issues Statement and Practice Resources on Exemplary Clinical Trial Site Attributes

ASCO Released EHR Field Guide


****CMS NEWS****
The transcript of the Centers for Medicare & Medicaid Services (CMS) ICD-10-CM/PCS National Provider Conference Call for Physicians that was held on November 17, 2008 is now available at
http://www.cms.hhs.gov/ICD10/Downloads/November17calltranscript.pdf .

CMS has updated the ICD-10 download files by posting the 2009 version of the following documents at http://www.cms.hhs.gov/ICD10/02_ICD-10-PCS.asp :
• ICD-10 General Equivalence Mappings (these refer to procedure codes)
• Reimbursement mappings and guides for the use of the Mappings
• 2009 version of ICD-10-Procedure Coding System (PCS)
• ICD-10 version of the digestive Medicare Severity Diagnosis Related Groups (MS-DRG)

The 2009 ICD-10-CM (Diagnosis codes) General Equivalence Mappings have been posted at http://www.cms.hhs.gov/ICD10/03_ICD_10_CM.asp .

The 2009 version of ICD-10-Clinical Modifications (CM), Diagnoses, will be posted by the end of December 2008 on the following sites:
http://www.cdc.gov/nchs/icd9.htm
http://www.cms.hhs.gov/ICD10/03_ICD_10_CM.asp

If you are unable to access any of the hyperlinks in this message, please copy and paste the URL into your Internet browser.


The Centers for Medicare & Medicaid Services (CMS) is pleased to announce the release of the detailed specifications for the 2009 Physician Quality Reporting Initiative (PQRI) measures and the 2009 PQRI measures groups. The following resources have been posted to the PQRI webpage on the CMS website:

2009 PQRI Quality Measure Specifications Manual and Release Notes- Contains the detailed specifications (including codes and reporting instructions) for the 153 2009 PQRI quality measures for claims or registry-based reporting and a summary of the changes from the 2008 PQRI Measure Specifications (in the form of release notes delineated by measure number).

2009 PQRI Implementation Guide - Provides guidance about how to implement 2009 PQRI claims-based reporting of measures to facilitate satisfactory reporting of quality data codes by eligible professionals for the 2009 PQRI.

2009 PQRI Measures Group Specifications Manual and Release Notes- Contains the detailed specifications and instructions for the seven (7) 2009 PQRI measures groups and a summary of the changes from the 2008 PQRI Measures Groups Specifications (in the form of release notes).

Getting Started with 2009 PQRI Reporting of Measures Groups - Provides guidance about implementing the 2009 PQRI measures groups.

To access the 2009 PQRI Quality Measure Specifications Manual and Release Notes, the 2009 PQRI Implementation Guide, the 2009 PQRI Measures Group Specifications Manual and Release Notes, or the Getting Started with 2009 PQRI Reporting of Measures Groups, visit http://www.cms.hhs.gov/PQRI/15_MeasuresCodes.asp#TopOfPage on the CMS website. Once on the Measure/Codes page, scroll down to the “Downloads” section and click on the appropriate link.

Please note that the 2009 PQRI quality measure specifications for any given quality measure may be different from specifications for the same quality measure used in 2008. Therefore, specifications for all 2009 PQRI quality measures, whether or not included in the 2008 PQRI program, must be obtained from the 2009 PQRI Quality Measure Specifications Manual.

In addition, measures group specifications are different from the specifications for individually reported measures that form the group. Therefore, the specifications and reporting instructions for the 2009 PQRI measures groups must be obtained from the 2009 PQRI Measures Group Specifications Manual.

Reporting for the 2009 PQRI begins January 1, 2009. Please note there is no need to sign up or pre-register in order to participate.

The Centers for Medicare & Medicaid Services (CMS) is pleased to announce a new section page on the Physician Quality Reporting Initiative web page. The “Spotlight” section page can be accessed on PQRI web page at http://www.cms.hhs.gov/pqri/ on the CMS website and click on the Spotlight tab. The “Spotlight” page is updated frequently and was created to alert eligible professionals to the newest program information available on the PQRI web page.

Detailed information on the 2009 PQRI may be found in the 2009 Medicare Physician Fee Schedule final rule with comment period (73 FR 69817 through 69847) that was published in the Federal Register on November 19, 2008. The final rule with comment period can be found in the “Related Links Outside of CMS” section of the Physician Quality Reporting Initiative website at: http://edocket.access.gpo.gov/2008/pdf/E8-26213.pdf on the CMS website.


****DHCS/MediCal NEWS****
Effective for dates of service on or after February 1, 2009, providers may no longer bill Medi-Cal using a recipient’s Social Security Number (SSN). Claims submitted with a recipient’s SSN will be denied. All exemptions to this policy are discontinued except for Medicare crossover claims. Providers may continue to bill Medicare crossover claims using the recipient’s SSN.

Claims submitted with a valid nine-digit Client Index Number will continue to be accepted. However, all providers are expected to use the Medi-Cal identification number from the recipient’s Benefits Identification Card (BIC) or paper ID card when verifying eligibility, billing Medi-Cal or submitting Treatment Authorization Requests (TARs).

Medi-Cal recognizes the importance of protecting the identity and health information of recipients and strongly encourages all providers to avoid using a recipient’s SSN whenever possible.

This notice has been published on the Medi-Cal Web site, http://www.medi-cal.ca.gov/, as a link from the home page Newsroom section.


****PALMETTO/J1MAC NEWS****
12/18/08 Part B LCD Update
http://www.palmettogba.com/palmetto/providers.nsf/DocsCat/Providers~Jurisdiction%201%20Part%20B~121808%20Part%20B%20LCD%20Update?opendocument

This is the 12/18/08 Part B LCD Update. It contains Ambulance Services
(J1B-08-0007-L), Cardiovascular Nuclear Medicine: Myocardial Perfusion
Imaging & Cardiac Blood Pool Studies (J1B-08-0018-L), Category III CPT
Codes (J1B-08-0020-L), Diabetes Mellitus Therapy Using Hepatic Activation
or PIVIT Therapy (J1B-08-0024-L), Genetic Testing (J1B-08-0036-L),
Gonadotropin Releasing Hormone Analogs (J1B-08-0046-L), Intravenous Immune
Globulin IVIg, J1B-08-0047-L), Psychotherapy Services (J1B-08-0066-L),
Treatment of Obstructive Sleep Apnea (J1B-08-0079-L) and Nervous System
Studies- Autonomic Function, Nerve Conduction and Electromyography
(J1B-08-0054-L).


January 2009 J1 A/B MAC Medicare Advisory
http://www.palmettogba.com/palmetto/providers.nsf/DocsCat/Providers~Jurisdiction%201%20Part%20A~Publications~Medicare%20Advisory~January%202009%20J1%20AB%20MAC%20Medicare%20Advisory?opendocument

The January 2009 J1 A/B MAC Medicare Advisory is now available to be viewed
on the Palmetto GBA Web site.